Dr Reddy's in the news

  • No Indian pharma firm is tier-I: Dr. Reddy's CEO

    Vice-chairman and CEO, GV Prasad, talks about the strengths and weaknesses of the domestic pharma industry, the challenges facing DRL, its $3-billion target and the government's thoughts on FDI in pharma, in a candid conversation with ET.

    Click Here for the Complete Story [PDF Format]
  • Father, scientist, pharma czar

    Dr. Reddy’s Labs, the first private enterprise that took pharma MNCs head on, will shortly celebrate its silver jubilee, Dr. Anji Reddy and his son Satish Reddy talk exclusively to Deccan Chronicle about the remarkable journey of the largest Indian pharma

    Click Here for the Complete Story [PDF Format]
  • Reddy Formula

    25 years of robust, healthy way of doing business.

    Click Here for the Complete Story [PDF Format]